Related Experiment Video
Updated: Jan 28, 2026
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
Published on: June 14, 2018
Double-negative T cells remarkably promote neuroinflammation after ischemic stroke
Hailan Meng1,2,3,4,5, Haoran Zhao1,2, Xiang Cao1,2,3,4,5
1Department of Neurology of Drum Tower Hospital, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, 210008 Nanjing, China.
Double-negative T cells (DNTs) increase in the brain after stroke, worsening injury. Blocking their inflammatory pathway improved stroke outcomes in mice, identifying DNTs as a potential therapeutic target.
Area of Science:
- Neuroimmunology
- Immunology
- Stroke Research
Background:
- Double-negative T cells (DNTs) regulate immune homeostasis in peripheral diseases.
- The role of DNTs in the central nervous system, particularly during stroke, is not well understood.
Purpose of the Study:
- To investigate the function and impact of DNTs in the central nervous system following ischemic stroke.
- To explore DNTs as a potential therapeutic target for stroke treatment.
Main Methods:
- Quantification of DNT levels in the brain and blood of stroke patients and a mouse model.
- Analysis of the molecular pathways modulated by DNTs in ischemic brain injury.
- Evaluation of therapeutic blockade of the FasL/PTPN2/TNF-α pathway in a mouse stroke model.
Main Results:
- DNT levels significantly increased in the brain and blood during stroke in a time-dependent manner.
- Infiltrating DNTs exacerbated ischemic brain injury by enhancing neuroinflammation via the FasL/PTPN2/TNF-α pathway.
- Blocking this pathway reduced DNT-mediated neuroinflammation and improved stroke outcomes in mice.
Conclusions:
- DNTs play a critical role in exacerbating ischemic brain injury by promoting neuroinflammation.
- Targeting the FasL/PTPN2/TNF-α pathway offers a promising therapeutic strategy for stroke.
- DNTs represent a novel and attractive target for treating ischemic stroke.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Negative Regulator Molecules
Fixing Double-strand Breaks
Positive, Negative, and Zero Work
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

